Skip to content

A Study to determine the Factors Affecting the  Survival in Patients with Gastric cancer Undergoing Surgery

A Prospective and Retrospective study to determine the Factors Affecting Disease Free Survival and Overall Survival in Patients with Gastric cancer Undergoing Curative Surgery

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2011/091/000221
Enrollment
250
Registered
2011-03-01
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Gastric cancer patient undergoing curative surgery

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

Health Care Global Enterprises Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Gastric adenocarcinoma  ECOG Performance Status  junction from above)  No evidence of metastatic disease on PET CT  (or other  investigations carried out  for  metastatic work up)  Tumour  infiltrating  adjacent  organs  (T4  disease),  if  the  involved  organ  has  been  resected at the time of surgery No evidence of Ascites   Peritoneal cytology negative for malignant cell if done  Surgery performed at a HCG centre  Surgery described as curative by the surgeon   Surgery performed upfront or after neoadjuvant chemotherapy/or chemoradiation.Â

Exclusion criteria

Exclusion criteria: Stage  4  disease  found  during  surgery  (peritoneal  deposits,  liver metastasis,  ascites,  omental nodules, discontinuous with the primary tumour)   Patient  who  had  stage  4  disease  at  the  outset  e.g.  Ascites,  has  responded  to chemotherapy and has undergone surgery.   The patient has undergone Ivor Lewis Operation for proximal gastric cancer. 

Design outcomes

Primary

MeasureTime frame
1. Response to treatment 2. Timeâ??to relapse  3. Diseaseâ??free survivalTimepoint: 2 years

Secondary

MeasureTime frame
overall survival (calculated as the time in months from the start of treatment till death due to any cause)Timepoint:

Countries

India

Contacts

Public ContactDr. ChennaKeshava

Investigator

aditimodi31@gmail.com08040206000

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026